Digoxin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Digoxin" in English language version.

refsWebsite

Global rank English rank

51nih.gov

4^th place

36doi.org

2^nd place

15web.archive.org

1^st place

9semanticscholar.org

11^th place

8^th place

5harvard.edu

18^th place

17^th place

4books.google.com

3^rd place

3handle.net

102^nd place

76^th place

2drugs.com

399^th place

333^rd place

2sciencedirect.com

149^th place

178^th place

2clincalc.com

3,912^th place

2,496^th place

1lexico.com

1,242^nd place

853^rd place

1wordreference.com

3,333^rd place

5,346^th place

1archive.org

6^th place

1archive.today

14^th place

1adisonline.com

low place

1pharmacomicrobiomics.com

low place

1gutenberg.org

489^th place

377^th place

1nature.com

234^th place

397^th place

1wiktionary.org

649^th place

827^th place

1rsc.org

2,020^th place

1,872^nd place

1usatoday.com

41^st place

34^th place

1fda.gov

447^th place

338^th place

1usrecallnews.com

low place

1wsj.com

79^th place

65^th place

1nhs.uk

1,989^th place

1,528^th place

1clevelandclinic.org

4,925^th place

3,597^th place

adisonline.com

drugsafety.adisonline.com

Flanagan RJ, Jones AL (2004). "Fab antibody fragments: some applications in clinical toxicology". Drug Safety. 27 (14): 1115–33. doi:10.2165/00002018-200427140-00004. PMID 15554746. S2CID 40869324. Archived from the original on January 16, 2013. Retrieved July 16, 2007.

archive.org

Withering W (1785). An Account of the Foxglove and some of its Medical Uses. Birmingham, England: M. Swinney.

archive.today

Flanagan RJ, Jones AL (2004). "Fab antibody fragments: some applications in clinical toxicology". Drug Safety. 27 (14): 1115–33. doi:10.2165/00002018-200427140-00004. PMID 15554746. S2CID 40869324. Archived from the original on January 16, 2013. Retrieved July 16, 2007.

books.google.com

Cartwright AC (2016). The British Pharmacopoeia, 1864 to 2014: Medicines, International Standards and the State. Routledge. p. 183. ISBN 9781317039792. Archived from the original on 2017-09-08.
Paul M, Lichtenberg S, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD (2011-08-24). Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. John Wiley & Sons. ISBN 9781444358476. Archived from the original on 2017-09-08.
Dart RC (2004). "Digoxin and Therapeutic Cardiac Glycosides". Medical Toxicology. Lippincott Williams & Wilkins. p. 700. ISBN 978-0-7817-2845-4. Archived from the original on 2017-09-08. Retrieved 2016-12-15.()
Culpeper N (1652). The English Physician, Etc (1st ed.). London: William Bentley. pp. 97–98. Retrieved 22 January 2023.

clevelandclinic.org

my.clevelandclinic.org

"Digoxin Tablets: Uses & Side Effects". Cleveland Clinic. Retrieved 2024-01-24.

clincalc.com

"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
"Digoxin - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.

doi.org

Patocka J, Nepovimova E, Wu W, Kuca K (October 2020). "Digoxin: Pharmacology and toxicology-A review". Environmental Toxicology and Pharmacology. 79: 103400. doi:10.1016/j.etap.2020.103400. PMID 32464466. S2CID 218950180.
Hollman A (April 1996). "Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata". BMJ. 312 (7035): 912. doi:10.1136/bmj.312.7035.912. PMC 2350584. PMID 8611904.
Sticherling C, Oral H, Horrocks J, Chough SP, Baker RL, Kim MH, et al. (November 2000). "Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness". Circulation. 102 (20): 2503–8. doi:10.1161/01.CIR.102.20.2503. PMID 11076824. S2CID 127927.
Hallberg P, Lindbäck J, Lindahl B, Stenestrand U, Melhus H (October 2007). "Digoxin and mortality in atrial fibrillation: a prospective cohort study". European Journal of Clinical Pharmacology. 63 (10): 959–71. doi:10.1007/s00228-007-0346-9. PMID 17684738. S2CID 30951337.
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. (July 2019). "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons". Circulation. 140 (2): e125 – e151. doi:10.1161/CIR.0000000000000665. PMID 30686041. S2CID 59304609.
Ouyang AJ, LvYN, Zhong HL, Wen JH, Wei XH, Peng HW, et al. (April 2015). "Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation". The American Journal of Cardiology. 115 (7): 901–906. doi:10.1016/j.amjcard.2015.01.013. PMID 25660972.
Vamos M, Erath JW, Hohnloser SH (July 2015). "Digoxin-associated mortality: a systematic review and meta-analysis of the literature". European Heart Journal. 36 (28): 1831–1838. doi:10.1093/eurheartj/ehv143. PMID 25939649.
Sethi NJ, Nielsen EE, Safi S, Feinberg J, Gluud C, Jakobsen JC (2018-03-08). "Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials". PLOS ONE. 13 (3): e0193924. Bibcode:2018PLoSO..1393924S. doi:10.1371/journal.pone.0193924. PMC 5843263. PMID 29518134.
Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, et al. (August 2015). "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data". BMJ. 351: h4451. doi:10.1136/bmj.h4451. PMC 4553205. PMID 26321114.
Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, et al. (August 2015). "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data". BMJ. 351: h4451. doi:10.1136/bmj.h4451. PMC 4553205. PMID 26321114.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. (September 2021). "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure". European Heart Journal. 42 (36). European Society of Cardiology: 3599–3726. doi:10.1093/eurheartj/ehab368. PMID 34447992.
Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, et al. (November 2017). "2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure". The Canadian Journal of Cardiology. 33 (11): 1342–1433. doi:10.1016/j.cjca.2017.08.022. PMID 29111106.
Moscovitz T, Aldrighi JM, Abrahanshon PA, Zorn TM, Logullo AF, Gebara OC, et al. (April 2005). "Repercussions of digoxin, digitoxin and estradiol on the endometrial histomorphometry of oophorectomized mice". Gynecological Endocrinology. 20 (4): 213–20. doi:10.1080/09513590400021219. PMID 16019364. S2CID 22855158.
Thompson DF, Carter JR (1993). "Drug-induced gynecomastia". Pharmacotherapy. 13 (1): 37–45. doi:10.1002/j.1875-9114.1993.tb02688.x. PMID 8094898. S2CID 30322620.
Flanagan RJ, Jones AL (2004). "Fab antibody fragments: some applications in clinical toxicology". Drug Safety. 27 (14): 1115–33. doi:10.2165/00002018-200427140-00004. PMID 15554746. S2CID 40869324. Archived from the original on January 16, 2013. Retrieved July 16, 2007.
Wang W, Chen JS, Zucker IH (June 1990). "Carotid sinus baroreceptor sensitivity in experimental heart failure". Circulation. 81 (6): 1959–66. doi:10.1161/01.cir.81.6.1959. PMID 2344687.
Gheorghiade M, Adams KF, Colucci WS (June 2004). "Digoxin in the management of cardiovascular disorders". Circulation. 109 (24): 2959–64. doi:10.1161/01.cir.0000132482.95686.87. PMID 15210613. S2CID 33752611.
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. (September 2005). "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society". Circulation. 112 (12): e154-235. doi:10.1161/CIRCULATIONAHA.105.167586. PMID 16160202.
Rathore SS, Wang Y, Krumholz HM (October 2002). "Sex-based differences in the effect of digoxin for the treatment of heart failure". The New England Journal of Medicine. 347 (18): 1403–11. doi:10.1056/NEJMoa021266. PMID 12409542.
Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, et al. (March 2010). "Membrane transporters in drug development". Nature Reviews. Drug Discovery. 9 (3): 215–236. doi:10.1038/nrd3028. PMC 3326076. PMID 20190787.
Fromm MF (February 2000). "P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs". Int J Clin Pharmacol Ther. 38 (2): 69–74. doi:10.5414/cpp38069. PMID 10706193.
Schinkel AH (April 1999). "P-Glycoprotein, a gatekeeper in the blood-brain barrier". Adv Drug Deliv Rev. 36 (2–3): 179–194. doi:10.1016/s0169-409x(98)00085-4. PMID 10837715.
Mathan VI, Wiederman J, Dobkin JF, Lindenbaum J (July 1989). "Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora". Gut. 30 (7): 971–7. doi:10.1136/gut.30.7.971. PMC 1434295. PMID 2759492.
Lindenbaum J, Rund DG, Butler VP, Tse-Eng D, Saha JR (October 1981). "Inactivation of digoxin by the gut flora: reversal by antibiotic therapy". The New England Journal of Medicine. 305 (14): 789–94. doi:10.1056/NEJM198110013051403. PMID 7266632.
Cushny AR (1925). "The Action and Uses in Medicine of Digitalis and its Allies". Nature. 116 (2905) (1st ed.). London: Longmans, Green and Co: 8–9. Bibcode:1925Natur.116....8.. doi:10.1038/116008a0. hdl:2027/uc1.b3846609. S2CID 9025850.
Smith S (1930). "LXXII.—Digoxin, a new digitalis glucoside". J. Chem. Soc. The Royal Society of Chemistry: 508–510. doi:10.1039/JR9300000508. Archived from the original on 2021-06-02. Retrieved 2020-10-22.
Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, et al. (December 2008). "Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth". Proceedings of the National Academy of Sciences of the United States of America (re: glycosides). 105 (50): 19579–86. Bibcode:2008PNAS..10519579Z. doi:10.1073/pnas.0809763105. PMC 2604945. PMID 19020076.
Lopez-Lazaro M (March 2009). "Digoxin, HIF-1, and cancer". Proceedings of the National Academy of Sciences of the United States of America. 106 (9): E26, author reply E27. Bibcode:2009PNAS..106E..26L. doi:10.1073/pnas.0813047106. PMC 2651277. PMID 19240208.
Dal Canto MC (May 1989). "AIDS and the nervous system: current status and future perspectives". Human Pathology. 20 (5): 410–8. doi:10.1016/0046-8177(89)90004-x. PMID 2651280.
Yokoyama S, Sugimoto Y, Nakagawa C, Hosomi K, Takada M (November 2019). "Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin". Scientific Reports. 9 (1): 16597. Bibcode:2019NatSR...916597Y. doi:10.1038/s41598-019-53392-y. PMC 6851125. PMID 31719612.
Kaapu KJ, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A (November 2016). "Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer". British Journal of Cancer. 115 (11): 1289–1295. doi:10.1038/bjc.2016.328. PMC 5129833. PMID 27755533.
Biggar RJ, Wohlfahrt J, Oudin A, Hjuler T, Melbye M (June 2011). "Digoxin use and the risk of breast cancer in women". Journal of Clinical Oncology. 29 (16): 2165–70. doi:10.1200/JCO.2010.32.8146. PMID 21422417.
Biggar RJ, Andersen EW, Kroman N, Wohlfahrt J, Melbye M (February 2013). "Breast cancer in women using digoxin: tumor characteristics and relapse risk". Breast Cancer Research. 15 (1): R13. doi:10.1186/bcr3386. PMC 3672748. PMID 23421975.
Ahern TP, Tamimi RM, Rosner BA, Hankinson SE (April 2014). "Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis". Breast Cancer Research and Treatment. 144 (2): 427–35. doi:10.1007/s10549-014-2886-x. PMC 4010120. PMID 24573543.
Deng K, Shen J, Wang W, Li M, Li H, Chen C, et al. (2019-01-02). "Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer". Cancer Biology & Therapy. 20 (1): 52–64. doi:10.1080/15384047.2018.1504723. PMC 6343689. PMID 30183476.
Chung MH, Wang YW, Chang YL, Huang SM, Lin WS (July 2017). "Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification". Oncotarget. 8 (27): 44203–44216. doi:10.18632/oncotarget.17410. PMC 5546474. PMID 28496002.

drugs.com

"Digoxin Use During Pregnancy". Drugs.com. Archived from the original on 21 December 2016. Retrieved 14 December 2016.
"Digoxin". The American Society of Health-System Pharmacists. Archived from the original on 21 December 2016. Retrieved 8 December 2016.

fda.gov

"Recalls, Market Withdrawals & Safety Alerts". Federal Drugs Administration. 2008-10-15. Archived from the original on 2008-05-02. Retrieved 2011-11-08.

gutenberg.org

Withering W (1785). An Account of the Foxglove and some of its Medical Uses With Practical Remarks on Dropsy and Other Diseases. Archived from the original on 2017-09-08.

handle.net

hdl.handle.net

World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 270. hdl:10665/44053. ISBN 9789241547659.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Cushny AR (1925). "The Action and Uses in Medicine of Digitalis and its Allies". Nature. 116 (2905) (1st ed.). London: Longmans, Green and Co: 8–9. Bibcode:1925Natur.116....8.. doi:10.1038/116008a0. hdl:2027/uc1.b3846609. S2CID 9025850.

harvard.edu

ui.adsabs.harvard.edu

Sethi NJ, Nielsen EE, Safi S, Feinberg J, Gluud C, Jakobsen JC (2018-03-08). "Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials". PLOS ONE. 13 (3): e0193924. Bibcode:2018PLoSO..1393924S. doi:10.1371/journal.pone.0193924. PMC 5843263. PMID 29518134.
Cushny AR (1925). "The Action and Uses in Medicine of Digitalis and its Allies". Nature. 116 (2905) (1st ed.). London: Longmans, Green and Co: 8–9. Bibcode:1925Natur.116....8.. doi:10.1038/116008a0. hdl:2027/uc1.b3846609. S2CID 9025850.
Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, et al. (December 2008). "Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth". Proceedings of the National Academy of Sciences of the United States of America (re: glycosides). 105 (50): 19579–86. Bibcode:2008PNAS..10519579Z. doi:10.1073/pnas.0809763105. PMC 2604945. PMID 19020076.
Lopez-Lazaro M (March 2009). "Digoxin, HIF-1, and cancer". Proceedings of the National Academy of Sciences of the United States of America. 106 (9): E26, author reply E27. Bibcode:2009PNAS..106E..26L. doi:10.1073/pnas.0813047106. PMC 2651277. PMID 19240208.
Yokoyama S, Sugimoto Y, Nakagawa C, Hosomi K, Takada M (November 2019). "Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin". Scientific Reports. 9 (1): 16597. Bibcode:2019NatSR...916597Y. doi:10.1038/s41598-019-53392-y. PMC 6851125. PMID 31719612.

lexico.com

"Digoxin". Digoxin | Definition of Digoxin by Lexico. Lexico. Archived from the original on 27 October 2019. Retrieved 28 October 2019.

nature.com

Cushny AR (1925). "The Action and Uses in Medicine of Digitalis and its Allies". Nature. 116 (2905) (1st ed.). London: Longmans, Green and Co: 8–9. Bibcode:1925Natur.116....8.. doi:10.1038/116008a0. hdl:2027/uc1.b3846609. S2CID 9025850.

nhs.uk

"Digoxin: a medicine to treat heart problems". nhs.uk. 2021-09-15. Retrieved 2024-01-24.

nih.gov

pubmed.ncbi.nlm.nih.gov

Patocka J, Nepovimova E, Wu W, Kuca K (October 2020). "Digoxin: Pharmacology and toxicology-A review". Environmental Toxicology and Pharmacology. 79: 103400. doi:10.1016/j.etap.2020.103400. PMID 32464466. S2CID 218950180.
Hollman A (April 1996). "Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata". BMJ. 312 (7035): 912. doi:10.1136/bmj.312.7035.912. PMC 2350584. PMID 8611904.
Sticherling C, Oral H, Horrocks J, Chough SP, Baker RL, Kim MH, et al. (November 2000). "Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness". Circulation. 102 (20): 2503–8. doi:10.1161/01.CIR.102.20.2503. PMID 11076824. S2CID 127927.
Hallberg P, Lindbäck J, Lindahl B, Stenestrand U, Melhus H (October 2007). "Digoxin and mortality in atrial fibrillation: a prospective cohort study". European Journal of Clinical Pharmacology. 63 (10): 959–71. doi:10.1007/s00228-007-0346-9. PMID 17684738. S2CID 30951337.
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. (July 2019). "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons". Circulation. 140 (2): e125 – e151. doi:10.1161/CIR.0000000000000665. PMID 30686041. S2CID 59304609.
Ouyang AJ, LvYN, Zhong HL, Wen JH, Wei XH, Peng HW, et al. (April 2015). "Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation". The American Journal of Cardiology. 115 (7): 901–906. doi:10.1016/j.amjcard.2015.01.013. PMID 25660972.
Vamos M, Erath JW, Hohnloser SH (July 2015). "Digoxin-associated mortality: a systematic review and meta-analysis of the literature". European Heart Journal. 36 (28): 1831–1838. doi:10.1093/eurheartj/ehv143. PMID 25939649.
Sethi NJ, Nielsen EE, Safi S, Feinberg J, Gluud C, Jakobsen JC (2018-03-08). "Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials". PLOS ONE. 13 (3): e0193924. Bibcode:2018PLoSO..1393924S. doi:10.1371/journal.pone.0193924. PMC 5843263. PMID 29518134.
Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, et al. (August 2015). "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data". BMJ. 351: h4451. doi:10.1136/bmj.h4451. PMC 4553205. PMID 26321114.
Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, et al. (August 2015). "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data". BMJ. 351: h4451. doi:10.1136/bmj.h4451. PMC 4553205. PMID 26321114.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. (September 2021). "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure". European Heart Journal. 42 (36). European Society of Cardiology: 3599–3726. doi:10.1093/eurheartj/ehab368. PMID 34447992.
Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, et al. (November 2017). "2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure". The Canadian Journal of Cardiology. 33 (11): 1342–1433. doi:10.1016/j.cjca.2017.08.022. PMID 29111106.
Moscovitz T, Aldrighi JM, Abrahanshon PA, Zorn TM, Logullo AF, Gebara OC, et al. (April 2005). "Repercussions of digoxin, digitoxin and estradiol on the endometrial histomorphometry of oophorectomized mice". Gynecological Endocrinology. 20 (4): 213–20. doi:10.1080/09513590400021219. PMID 16019364. S2CID 22855158.
Thompson DF, Carter JR (1993). "Drug-induced gynecomastia". Pharmacotherapy. 13 (1): 37–45. doi:10.1002/j.1875-9114.1993.tb02688.x. PMID 8094898. S2CID 30322620.
Doering W, König E, Sturm W (March 1977). "[Digitalis intoxication: specifity and significance of cardiac and extracardiac symptoms. part I: Patients with digitalis-induced arrhythmias (author's transl)]" [Digitalis intoxication: specificity and significance of cardiac and extracardiac symptoms. Part I: Patients with Digitalis-induced arrhythmias]. Zeitschrift für Kardiologie (in German). 66 (3): 121–8. PMID 857452.
Flanagan RJ, Jones AL (2004). "Fab antibody fragments: some applications in clinical toxicology". Drug Safety. 27 (14): 1115–33. doi:10.2165/00002018-200427140-00004. PMID 15554746. S2CID 40869324. Archived from the original on January 16, 2013. Retrieved July 16, 2007.
Wang W, Chen JS, Zucker IH (June 1990). "Carotid sinus baroreceptor sensitivity in experimental heart failure". Circulation. 81 (6): 1959–66. doi:10.1161/01.cir.81.6.1959. PMID 2344687.
Gheorghiade M, Adams KF, Colucci WS (June 2004). "Digoxin in the management of cardiovascular disorders". Circulation. 109 (24): 2959–64. doi:10.1161/01.cir.0000132482.95686.87. PMID 15210613. S2CID 33752611.
King GS, Goyal A, Grigorova Y, Hashmi MF (2023). "Antiarrhythmic Medications". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29493947. Retrieved 7 May 2023.
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. (September 2005). "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society". Circulation. 112 (12): e154-235. doi:10.1161/CIRCULATIONAHA.105.167586. PMID 16160202.
Rathore SS, Wang Y, Krumholz HM (October 2002). "Sex-based differences in the effect of digoxin for the treatment of heart failure". The New England Journal of Medicine. 347 (18): 1403–11. doi:10.1056/NEJMoa021266. PMID 12409542.
Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, et al. (March 2010). "Membrane transporters in drug development". Nature Reviews. Drug Discovery. 9 (3): 215–236. doi:10.1038/nrd3028. PMC 3326076. PMID 20190787.
Fromm MF (February 2000). "P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs". Int J Clin Pharmacol Ther. 38 (2): 69–74. doi:10.5414/cpp38069. PMID 10706193.
Schinkel AH (April 1999). "P-Glycoprotein, a gatekeeper in the blood-brain barrier". Adv Drug Deliv Rev. 36 (2–3): 179–194. doi:10.1016/s0169-409x(98)00085-4. PMID 10837715.
Mathan VI, Wiederman J, Dobkin JF, Lindenbaum J (July 1989). "Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora". Gut. 30 (7): 971–7. doi:10.1136/gut.30.7.971. PMC 1434295. PMID 2759492.
Lindenbaum J, Rund DG, Butler VP, Tse-Eng D, Saha JR (October 1981). "Inactivation of digoxin by the gut flora: reversal by antibiotic therapy". The New England Journal of Medicine. 305 (14): 789–94. doi:10.1056/NEJM198110013051403. PMID 7266632.
Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, et al. (December 2008). "Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth". Proceedings of the National Academy of Sciences of the United States of America (re: glycosides). 105 (50): 19579–86. Bibcode:2008PNAS..10519579Z. doi:10.1073/pnas.0809763105. PMC 2604945. PMID 19020076.
Lopez-Lazaro M (March 2009). "Digoxin, HIF-1, and cancer". Proceedings of the National Academy of Sciences of the United States of America. 106 (9): E26, author reply E27. Bibcode:2009PNAS..106E..26L. doi:10.1073/pnas.0813047106. PMC 2651277. PMID 19240208.
Dal Canto MC (May 1989). "AIDS and the nervous system: current status and future perspectives". Human Pathology. 20 (5): 410–8. doi:10.1016/0046-8177(89)90004-x. PMID 2651280.
Yokoyama S, Sugimoto Y, Nakagawa C, Hosomi K, Takada M (November 2019). "Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin". Scientific Reports. 9 (1): 16597. Bibcode:2019NatSR...916597Y. doi:10.1038/s41598-019-53392-y. PMC 6851125. PMID 31719612.
Kaapu KJ, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A (November 2016). "Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer". British Journal of Cancer. 115 (11): 1289–1295. doi:10.1038/bjc.2016.328. PMC 5129833. PMID 27755533.
Biggar RJ, Wohlfahrt J, Oudin A, Hjuler T, Melbye M (June 2011). "Digoxin use and the risk of breast cancer in women". Journal of Clinical Oncology. 29 (16): 2165–70. doi:10.1200/JCO.2010.32.8146. PMID 21422417.
Biggar RJ, Andersen EW, Kroman N, Wohlfahrt J, Melbye M (February 2013). "Breast cancer in women using digoxin: tumor characteristics and relapse risk". Breast Cancer Research. 15 (1): R13. doi:10.1186/bcr3386. PMC 3672748. PMID 23421975.
Ahern TP, Tamimi RM, Rosner BA, Hankinson SE (April 2014). "Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis". Breast Cancer Research and Treatment. 144 (2): 427–35. doi:10.1007/s10549-014-2886-x. PMC 4010120. PMID 24573543.
Deng K, Shen J, Wang W, Li M, Li H, Chen C, et al. (2019-01-02). "Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer". Cancer Biology & Therapy. 20 (1): 52–64. doi:10.1080/15384047.2018.1504723. PMC 6343689. PMID 30183476.
Chung MH, Wang YW, Chang YL, Huang SM, Lin WS (July 2017). "Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification". Oncotarget. 8 (27): 44203–44216. doi:10.18632/oncotarget.17410. PMC 5546474. PMID 28496002.

ncbi.nlm.nih.gov

Hollman A (April 1996). "Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata". BMJ. 312 (7035): 912. doi:10.1136/bmj.312.7035.912. PMC 2350584. PMID 8611904.
Sethi NJ, Nielsen EE, Safi S, Feinberg J, Gluud C, Jakobsen JC (2018-03-08). "Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials". PLOS ONE. 13 (3): e0193924. Bibcode:2018PLoSO..1393924S. doi:10.1371/journal.pone.0193924. PMC 5843263. PMID 29518134.
Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, et al. (August 2015). "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data". BMJ. 351: h4451. doi:10.1136/bmj.h4451. PMC 4553205. PMID 26321114.
Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, et al. (August 2015). "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data". BMJ. 351: h4451. doi:10.1136/bmj.h4451. PMC 4553205. PMID 26321114.
King GS, Goyal A, Grigorova Y, Hashmi MF (2023). "Antiarrhythmic Medications". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29493947. Retrieved 7 May 2023.
Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, et al. (March 2010). "Membrane transporters in drug development". Nature Reviews. Drug Discovery. 9 (3): 215–236. doi:10.1038/nrd3028. PMC 3326076. PMID 20190787.
Mathan VI, Wiederman J, Dobkin JF, Lindenbaum J (July 1989). "Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora". Gut. 30 (7): 971–7. doi:10.1136/gut.30.7.971. PMC 1434295. PMID 2759492.
Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, et al. (December 2008). "Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth". Proceedings of the National Academy of Sciences of the United States of America (re: glycosides). 105 (50): 19579–86. Bibcode:2008PNAS..10519579Z. doi:10.1073/pnas.0809763105. PMC 2604945. PMID 19020076.
Lopez-Lazaro M (March 2009). "Digoxin, HIF-1, and cancer". Proceedings of the National Academy of Sciences of the United States of America. 106 (9): E26, author reply E27. Bibcode:2009PNAS..106E..26L. doi:10.1073/pnas.0813047106. PMC 2651277. PMID 19240208.
Yokoyama S, Sugimoto Y, Nakagawa C, Hosomi K, Takada M (November 2019). "Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin". Scientific Reports. 9 (1): 16597. Bibcode:2019NatSR...916597Y. doi:10.1038/s41598-019-53392-y. PMC 6851125. PMID 31719612.
Kaapu KJ, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A (November 2016). "Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer". British Journal of Cancer. 115 (11): 1289–1295. doi:10.1038/bjc.2016.328. PMC 5129833. PMID 27755533.
Biggar RJ, Andersen EW, Kroman N, Wohlfahrt J, Melbye M (February 2013). "Breast cancer in women using digoxin: tumor characteristics and relapse risk". Breast Cancer Research. 15 (1): R13. doi:10.1186/bcr3386. PMC 3672748. PMID 23421975.
Ahern TP, Tamimi RM, Rosner BA, Hankinson SE (April 2014). "Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis". Breast Cancer Research and Treatment. 144 (2): 427–35. doi:10.1007/s10549-014-2886-x. PMC 4010120. PMID 24573543.
Deng K, Shen J, Wang W, Li M, Li H, Chen C, et al. (2019-01-02). "Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer". Cancer Biology & Therapy. 20 (1): 52–64. doi:10.1080/15384047.2018.1504723. PMC 6343689. PMID 30183476.
Chung MH, Wang YW, Chang YL, Huang SM, Lin WS (July 2017). "Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification". Oncotarget. 8 (27): 44203–44216. doi:10.18632/oncotarget.17410. PMC 5546474. PMID 28496002.

pharmacomicrobiomics.com

"PharmacoMicrobiomics". pharmacomicrobiomics.com. Archived from the original on 2021-06-02. Retrieved 2020-08-13.

rsc.org

pubs.rsc.org

Smith S (1930). "LXXII.—Digoxin, a new digitalis glucoside". J. Chem. Soc. The Royal Society of Chemistry: 508–510. doi:10.1039/JR9300000508. Archived from the original on 2021-06-02. Retrieved 2020-10-22.

sciencedirect.com

Patocka J, Nepovimova E, Wu W, Kuca K (October 2020). "Digoxin: Pharmacology and toxicology-A review". Environmental Toxicology and Pharmacology. 79: 103400. doi:10.1016/j.etap.2020.103400. PMID 32464466. S2CID 218950180.
Cunningham L (2018). Cardiology Secrets. Elsevier. pp. 241–252. ISBN 978-0-323-47870-0. Archived from the original on 2021-04-20. Retrieved 2021-03-28.

semanticscholar.org

api.semanticscholar.org

Patocka J, Nepovimova E, Wu W, Kuca K (October 2020). "Digoxin: Pharmacology and toxicology-A review". Environmental Toxicology and Pharmacology. 79: 103400. doi:10.1016/j.etap.2020.103400. PMID 32464466. S2CID 218950180.
Sticherling C, Oral H, Horrocks J, Chough SP, Baker RL, Kim MH, et al. (November 2000). "Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness". Circulation. 102 (20): 2503–8. doi:10.1161/01.CIR.102.20.2503. PMID 11076824. S2CID 127927.
Hallberg P, Lindbäck J, Lindahl B, Stenestrand U, Melhus H (October 2007). "Digoxin and mortality in atrial fibrillation: a prospective cohort study". European Journal of Clinical Pharmacology. 63 (10): 959–71. doi:10.1007/s00228-007-0346-9. PMID 17684738. S2CID 30951337.
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. (July 2019). "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons". Circulation. 140 (2): e125 – e151. doi:10.1161/CIR.0000000000000665. PMID 30686041. S2CID 59304609.
Moscovitz T, Aldrighi JM, Abrahanshon PA, Zorn TM, Logullo AF, Gebara OC, et al. (April 2005). "Repercussions of digoxin, digitoxin and estradiol on the endometrial histomorphometry of oophorectomized mice". Gynecological Endocrinology. 20 (4): 213–20. doi:10.1080/09513590400021219. PMID 16019364. S2CID 22855158.
Thompson DF, Carter JR (1993). "Drug-induced gynecomastia". Pharmacotherapy. 13 (1): 37–45. doi:10.1002/j.1875-9114.1993.tb02688.x. PMID 8094898. S2CID 30322620.
Flanagan RJ, Jones AL (2004). "Fab antibody fragments: some applications in clinical toxicology". Drug Safety. 27 (14): 1115–33. doi:10.2165/00002018-200427140-00004. PMID 15554746. S2CID 40869324. Archived from the original on January 16, 2013. Retrieved July 16, 2007.
Gheorghiade M, Adams KF, Colucci WS (June 2004). "Digoxin in the management of cardiovascular disorders". Circulation. 109 (24): 2959–64. doi:10.1161/01.cir.0000132482.95686.87. PMID 15210613. S2CID 33752611.
Cushny AR (1925). "The Action and Uses in Medicine of Digitalis and its Allies". Nature. 116 (2905) (1st ed.). London: Longmans, Green and Co: 8–9. Bibcode:1925Natur.116....8.. doi:10.1038/116008a0. hdl:2027/uc1.b3846609. S2CID 9025850.

usatoday.com

"Victims' families set to confront killer". USA Today. 2006-01-01. Archived from the original on 2006-01-04.

usrecallnews.com

"Urgent Digitek Digoxin Recall". U.S. Recall News. 2008-04-28. Archived from the original on 2008-05-04. Retrieved 2009-07-25.

web.archive.org

"Digoxin". Digoxin | Definition of Digoxin by Lexico. Lexico. Archived from the original on 27 October 2019. Retrieved 28 October 2019.
"Digoxin Use During Pregnancy". Drugs.com. Archived from the original on 21 December 2016. Retrieved 14 December 2016.
"Digoxin". The American Society of Health-System Pharmacists. Archived from the original on 21 December 2016. Retrieved 8 December 2016.
Cartwright AC (2016). The British Pharmacopoeia, 1864 to 2014: Medicines, International Standards and the State. Routledge. p. 183. ISBN 9781317039792. Archived from the original on 2017-09-08.
"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
Paul M, Lichtenberg S, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD (2011-08-24). Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. John Wiley & Sons. ISBN 9781444358476. Archived from the original on 2017-09-08.
Cunningham L (2018). Cardiology Secrets. Elsevier. pp. 241–252. ISBN 978-0-323-47870-0. Archived from the original on 2021-04-20. Retrieved 2021-03-28.
Dart RC (2004). "Digoxin and Therapeutic Cardiac Glycosides". Medical Toxicology. Lippincott Williams & Wilkins. p. 700. ISBN 978-0-7817-2845-4. Archived from the original on 2017-09-08. Retrieved 2016-12-15.()
"PharmacoMicrobiomics". pharmacomicrobiomics.com. Archived from the original on 2021-06-02. Retrieved 2020-08-13.
Withering W (1785). An Account of the Foxglove and some of its Medical Uses With Practical Remarks on Dropsy and Other Diseases. Archived from the original on 2017-09-08.
Smith S (1930). "LXXII.—Digoxin, a new digitalis glucoside". J. Chem. Soc. The Royal Society of Chemistry: 508–510. doi:10.1039/JR9300000508. Archived from the original on 2021-06-02. Retrieved 2020-10-22.
"Victims' families set to confront killer". USA Today. 2006-01-01. Archived from the original on 2006-01-04.
"Recalls, Market Withdrawals & Safety Alerts". Federal Drugs Administration. 2008-10-15. Archived from the original on 2008-05-02. Retrieved 2011-11-08.
"Urgent Digitek Digoxin Recall". U.S. Recall News. 2008-04-28. Archived from the original on 2008-05-04. Retrieved 2009-07-25.
"Patients Sue Icelandic Drugmaker Over Recalled Heart Drug". The Wall Street Journal. 2008-05-09. Archived from the original on 2009-04-13. Retrieved 2009-07-25.

wiktionary.org

en.wiktionary.org

"digoxin". Wiktionary. Wikimedia. 16 January 2023. Retrieved 21 January 2023.

wordreference.com

"digoxin". WordReference. Retrieved 28 October 2019.

wsj.com

blogs.wsj.com

"Patients Sue Icelandic Drugmaker Over Recalled Heart Drug". The Wall Street Journal. 2008-05-09. Archived from the original on 2009-04-13. Retrieved 2009-07-25.